ID   KSE-1
AC   CVCL_VJ85
DR   Cosmic; 2650625
DR   Wikidata; Q95980267
RX   PubMed=2224855;
RX   PubMed=2469583;
RX   PubMed=3607755;
CC   Population: Japanese.
CC   Doubling time: ~19.5 hours (PubMed=3607755).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=2224855;
RA   Ueo, Hiroaki
RA   Matsuoka, Hideo
RA   Sugimachi, Keizo
RA   Kuwano, Hiroyuki
RA   Mori, Masaki
RA   Akiyoshi, Tsuyoshi
RT   "Inhibitory effects of estrogen on the growth of a human esophageal
RT   carcinoma cell line.";
RL   Cancer Res. 50:7212-7215(1990).
//
RX   PubMed=2469583; DOI=10.1159/000129003;
RA   Matsuoka, Hideo
RA   Sugimachi, Keizo
RA   Mori, Masaki
RA   Kuwano, Hiroyuki
RA   Ohno, S.
RA   Nakano, Shuji
RT   "Effects of hyperthermochemoradiotherapy on KSE-1 cells, a newly
RT   established human squamous cell line derived from esophageal
RT   carcinoma.";
RL   Eur. Surg. Res. 21:49-59(1989).
//
RX   PubMed=3607755;
RA   Matsuoka, Hideo
RA   Sugimachi, Keizo
RA   Ueo, Hiroaki
RA   Kuwano, Hiroyuki
RA   Nakano, Shuji
RA   Nakayama, Masaaki
RT   "Sex hormone response of a newly established squamous cell line
RT   derived from clinical esophageal carcinoma.";
RL   Cancer Res. 47:4134-4140(1987).
//